Take one 5mg tablet, three times a day
Abbreviations NAION: Nonarteritic anterior ischemic optic neuropathy RAPD: Relative afferent pupillary defect ODD: Optic disc drusen GLP-1 RA: Glucagon-like peptide-1 receptor agonist OCT: Optical coherence tomography ETDRS: Early Treatment Diabetic Retinopathy Study BMO: Bruchs membrane opening VA: Visual acuity IOP: Intraocular pressure GCA: Giant cell arteritis SAP: Standard automated perimetry MD: Mean deviation GCL: Ganglion cell layer EDI-OCT: Enhanced depth imaging optical coherence tomography VF: Visual field References Salvetat ML, Pellegrini F, Spadea L, Salati C, Zeppieri M
ROBYN PASHBY: We're at a point where we need to hold two truths, that GLP-1s are legitimate, evidence-based treatments for obesity but that they also sit inside our culture, which has intense weight pressure, weight stigma and eating disorder risk
Posso us-lo por quanto tempo
Root causes vary Doctors, patients and drug companies have learned a lot more in recent years about obesity and what works or doesn't since the new class of obesity treatments known as GLP-1 drugs have come to market
This includes checking for improvements in fatigue, weakness, and neurological issues
